Presentation is loading. Please wait.

Presentation is loading. Please wait.

OGDEN SURGICAL-MEDICAL SOCIETY 68TH ANNUAL CONFERENCE

Similar presentations


Presentation on theme: "OGDEN SURGICAL-MEDICAL SOCIETY 68TH ANNUAL CONFERENCE"— Presentation transcript:

1 OGDEN SURGICAL-MEDICAL SOCIETY 68TH ANNUAL CONFERENCE - 2013
What the LFTs are Telling You Avoiding Common Mistakes Norman L. Sussman, MD Baylor College of Medicine Houston, Texas

2 OGDEN SURGICAL-MEDICAL SOCIETY 68TH ANNUAL CONFERENCE - 2013
This presentation has no commercial content, promotes no commercial vendor and is not supported financially by any commercial vendor. I receive no financial remuneration from any commercial vendor related to this presentation

3 Question 1: Acute or Chronic?
Cirrhosis Platelets Imaging Chronicity & severity Prior studies Albumin Bilirubin INR Injury ALT/AST Cholestasis Alk Phos GGT 5’NT Biliary imaging U/S, MRCP, ERCP

4 Question 2: Hepatocellular or Cholestatic
ALT/ULN AP/ULN >5 = hepatocellular <2 = cholestatic Or, just look at the fold increase of ALT and AP Normal ALT Women < 19 IU/mL Men < 30 IU/mL

5 Aspartate Aminotransferase (AST/SGOT) Alanine Aminotransferase (ALT/SGPT) Markers of Cell Destruction ALT is more specific to the liver Usually higher in chronic liver injury (steady state) Viral hepatitis, AIH, NAFLD AST may be higher than ALT Cirrhosis Alcohol (pyridoxine deficiency) Early phase of acute liver injury Other organ damage – eg rhabdomyolysis, tumors

6 Acute Liver injury Acetaminophen, Shock, IV Amiodarone Dynamic AST/ALT Ratio
Peak injury about 48 hrs AST is initially 2x ALT Differential clearance AST – 50%/day ALT – 33%/day Equalize at about 96 hrs Bilirubin, INR, and creatinine are key to assessing survival Remien et al., Hepatology 2012

7 MALD Model of Acetaminophen-related Liver Damage
Remien et al., Hepatology 2012

8

9

10

11 Biliary Architecture - Bile Flow

12 Epithelial Cells are Polarized
Hollow Organ Liver Lumen = Bile Canaliculus = Brush Border Basolateral Aspect

13 Alkaline Phosphatase Located on the bile canliculus Three genes
Liver/kidney/bone Intestine Placenta (man and great apes) PI-glycan anchor (PI-g tailed proteins) GGT, 5’-nucleotidase GGT is inducible by alcohol Access to the sinusoid (blood side of the cell) Low in patients with Wilson disease Phospholipase C cleavage site

14 Albumin & AFP Proteins – made by the liver
AFP is the fetal analogue of albumin Made when cells revert to a fetal phenotype – part of a coordinated switch to fetal genes Liver regeneration (eg recovery from ALF) Inflammation (injury with regeneration) Liver cancer

15 Prealbumin Actually Transthyretin Transports thyroxine and retinol
Used to assess nutrition 2-4 day half life Affected by inflammation Mis-folded TTR is the most common protein in amyloid

16 Bilirubin Transport

17 Bilirubin Organic anion derived from hemoglobin
Measured by diazo (Van Den Bergh) reaction Direct (conjugated) vs. indirect Indirect – albumin-bound Direct – water soluble (urine) Delta (albumin-bound) – clears slowly Liver disease  conjugated bilirubinemia Jaundice may occur in right heart failure

18 Y = sufate, glucuronate Z = glycine, taurine NTCP – Na Taurocholate Cotransporting Polypeptide MRP2 – Multidrug Resistance Protein 2 BSEP – Bile Salt Export Protein OATP – Organic Anion Transport Protein

19 Canalicular Transporters & Diseases
FIC1 – PFIC1 BSEP – PFIC2 ABC G5/G8 – Sitosterolemia MDR3 – PFIC3 MRP2 – Dubin-Johnson Bile acids Conjugated Bilirubin & other conjugates Unknown Phospholipids Sterols

20 Coagulation Factors Liver makes factors I, II, V, VII, IX, X
PT/INR: I, II, V, VII, X Prolonged PT/INR: Congenital Liver failure Vitamin K deficiency Warfarin Vitamin K dependent factors: II, VII, IX, X FV – shortest half-life and not vitamin K dep. Vitamin K replacement

21 Ammonia Not especially useful Occasional adult with urea cycle defect

22 MELD Formula The Basis for Organ Allocation since Feb 2002
6.3 + ([0.957 x log creat] + [0.378 x log bili] + [1.12 x log INR] ) x 10 Score 90 Day Mortality (%) <10 2-8 10-19 6-29 20-29 50-76 30-39 62-83 >40 100

23 The 2g Sodium Diet Spot urine Na+>K+ predicts >78 mmol sodium excretion with 90% accuracy
2g Na+ = 88 mmole 78 mmol urinary + 10 mmol involuntary loss Patients who excrete >78 mmol/24h can be treated with 2g dietary restriction alone Assess excretion with 24h urinary sodium 24h creatinine excretion to test completeness 15 mg/kg for men) or 10 mg/kg for women If spot urine Na+>K+, the patient is excreting >78 mmol Na+ (i.e. consuming >2 Na+ per day)

24 Hyponatremia 997 consecutive patients from 28 centers in Europe, North and South America, and Asia for 28 days Inpatients and outpatients with cirrhosis and ascites Serum Sodium (mEq/L) <130 >135 Heptorenal Syndrome 3.45 1.75 1 (ref) Hepatic Encephalopathy 3.40 1.69 GI bleeding 1.48 0.93 Bacterial Peritonitis 2.36 1.44 Angeli P et al. Hepatology. 2006;44:1535–1542.

25 Hyponatremia – MELD-Na
Kim et al, NEJM 2008;359:

26 Liver Failure Liver injury ALT & AST Synthetic failure INR, F-V, F-VII
Albumin Bilirubin Portal hypertension Ascites/edema Encephalopathy Varices Renal failure Cardiomyopathy Pulmonary Disease

27 Viral Hepatitis Acute hepatitis panel
Anti-HAV IgM, anti-HBc IgM, HBsAg, anti-HCV The rest HAV immunity: anti-HAV (total) Anti-HBc (total), anti- HBs Viral titers: HBV DNA, HCV RNA

28 Hepatitis B Anti-HBc IgM – current infection or flare
IgG – prior infection HBsAg: current infection Anti-HBs: immunity (titer) HBeAg and anti-HBe: stage of disease

29 Autoimmune Markers AIH Usual: ANA, ASMA, anti-actin, LKM
Unusual: SLA, ASGP, ANCA Increased IgG PBC AMA Increased IgM PSC: None IgG4

30 Thyroiditis, colitis, others
Gender Female +2 HLA DR3 or DR4 +1 AP:AST (or ALT) ratio >3 <1.5 -2 Immune disease Thyroiditis, colitis, others -globulin or IgG above normal >2.0 <1.0 +3 Other markers Anti-SLA, actin, LC1, pANCA ANA, SMA, or anti-LKM1 titers >1:80 1:80 1:40 <1:40 Histological features Interface hepatitis Plasmacytic Rosettes None of above Biliary changes Other features -5 -3 AMA Positive -4 Treatment response Complete Relapse Viral markers Positive Negative Drugs Yes No Pretreatment score: Definite diagnosis Probable diagnosis >15 10-15 Alcohol <25 g/day >60 g/day Post-treatment score: Definite diagnosis Probable diagnosis > *Adapted from Alvarez F, Berg PA, Bianchi FB, et al. J. Hepatology 1999;31:

31 AMA-Positive & AMA-Negative PBC
Autoantibody AMA+ Group (%) AMA- Group (%) AMA 100 ANA 20-15 71-100 gp210 10-20 50 p63 25 Laminin B receptor <1 sp100 20-30 30-40 Promyelocytic leukemia protein 22 ? sp140 10 53 SOX13 10-15 Centromere <5 Laminin B 14-41 SMA 26-49 29 Vierling JM. Clin Liver Dis. 2004; 8:177-94

32 FibroTest/Fibrosure®
Five serum tests a-2 macroglbulin Haptoglobin GGT T-bilirubin Apolipoprotein A1 For a cutoff of 0.31, the negative predictive value for excluding significant fibrosis = 91%

33 49 year old female Admitted through the ER with jaundice, fever, chills, and RUQ pain for past three days Pain worse when the car hit a bump U/S: thickened gall bladder, large liver Murphy sign during u/s ALT 18 AST 36 AP 180 Bili/D 12.4/10.9 Alb 3.1 INR 2.3 WBC 18.7 Hb 11.4 Plate 98,0000

34 Does this patient need a cholecystectomy?
History Gallstones – mother and grandmother Works from home Drinks – 1-2 glasses of Scotch daily Diagnosis – acute alcoholic hepatitis

35 Summary ALT/AST = liver injury ALT is higher in hepatitis
AST his higher in acute liver injury and cirrhosis AP/GGT/5’NT = cholestasis Wilson disease = low AP AFP is an analogue of albumin = regeneration

36 Summary Bilirubin Direct = cholestasis & liver injury
Indirect = hemolysis, Gilbert Serum ammonia has little utility Occasional urea cycle defect PT/INR – higher in zone 3 necrosis Severe liver injury Hyperbilirubinemia Abnormal clotting


Download ppt "OGDEN SURGICAL-MEDICAL SOCIETY 68TH ANNUAL CONFERENCE"

Similar presentations


Ads by Google